Literature DB >> 12426603

Protective immunity of single and multi-antigen DNA vaccines against schistosomiasis.

E Nascimento1, I C Leão, V R A Pereira, Y M Gomes, P Chikhlikar, T August, E Marques, N Lucena-Silva.   

Abstract

We evaluated the usefulness of the combination of three plasmids encoding tegumental (pECL and pSM14) and muscular (pIRV5) antigens of the Schistosoma mansoni on improving the protective immunity over the use of a single antigen as DNA vaccines. Female BALB/c mice were inoculated twice with 25 micro g DNA plasmid within two weeks interval. The challenge was performed with 80 cercarias of a regional isolate of S. mansoni (SLM) one week after the last immunization. Six weeks after challenge, all mice were perfused for worm load determination. The following groups were analyzed: saline; empty vector; monovalent formulations of pECL; pSM14 and pIRV5 and also double combinations of pECL/pIRV5 and pIRV5/pSM14 and a triple combination of pECL/pIRV5/pSM14. The protection was expressed as a percentage of worm loads in each group compared with the saline group. The results obtained were 41% (p < 0.05); 52% (p < 0.05); 51% (p < 0.05); 48% (p < 0.05); 55% (p < 0.05); 45% (p < 0.05); 65% (p < 0.05) for each group respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426603     DOI: 10.1590/s0074-02762002000900021

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  7 in total

1.  Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4.

Authors:  Afzal A Siddiqui; Troy Phillips; Hugues Charest; Ron B Podesta; Martha L Quinlin; Justin R Pinkston; Jenny D Lloyd; Michelle Paz; Rachael M Villalovos; Janet Pompa
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Construction and expression of DNA vaccine pIRES-Sj97-Sj14-Sj26 and its immunogenicity in mice.

Authors:  Shuojie Liu; Jizhong Cheng; Chengwu Tang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-12

Review 3.  Schistosomiasis--an unusual cause of ureteral obstruction: a case history and perspective.

Authors:  Peter M Neal
Journal:  Clin Med Res       Date:  2004-11

Review 4.  Experimental vaccines in animal models for schistosomiasis.

Authors:  Afzal A Siddiqui; Gul Ahmad; Raymond T Damian; Ronald C Kennedy
Journal:  Parasitol Res       Date:  2008-02-08       Impact factor: 2.289

5.  Fasciola gigantica fatty acid binding protein (FABP) as a prophylactic agent against Schistosoma mansoni infection in CD1 mice.

Authors:  Ibrahim Rabia Aly; M Diab; A M El-Amir; M Hendawy; S Kadry
Journal:  Korean J Parasitol       Date:  2012-03-06       Impact factor: 1.341

6.  Fasciola hepatica vaccine: we may not be there yet but we're on the right road.

Authors:  Verónica Molina-Hernández; Grace Mulcahy; Jose Pérez; Álvaro Martínez-Moreno; Sheila Donnelly; Sandra M O'Neill; John P Dalton; Krystyna Cwiklinski
Journal:  Vet Parasitol       Date:  2015-01-15       Impact factor: 2.738

7.  Comparison of DNA vaccines producing HIV-1 Gag and LAMP/Gag chimera in rhesus macaques reveals antigen-specific T-cell responses with distinct phenotypes.

Authors:  Antonio Valentin; Priya Chikhlikar; Vainav Patel; Margherita Rosati; Milton Maciel; Kern-Hee Chang; Peter Silvera; Barbara K Felber; George N Pavlakis; J Thomas August; Ernesto T A Marques
Journal:  Vaccine       Date:  2009-06-17       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.